Answer
Breastfeeding should be discontinued during natalizumab treatment because natalizumab is excreted in human milk and its effect on newborns and infants is unknown.
Sources for this answer
- TYSABRI 300 mg concentrate for solution for infusionBiogen Idec Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 43Document updated
Sources checked